Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II AERAS-402 in BCG-vaccinated infants
PACTR201203000306280Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- May 2010
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in Tuberculosis (TB) comparing AERAS-402 with Placebo (2 arms). Primary endpoint: Tuberculosis disease. Started May 2010; status: completed.
02
Drugs
AERAS-402
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201203000306280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201203000306280.